Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toru Maruyama

Showing results (31-40 of 389) with videos related to

Pageof 39
Sort By:
Frontiers in Immunology|July 9, 2026
CD169-positive macrophages in lymph nodes and the tumor microenvironment: harnessing their biology for clinical diagnosis and anticancer therapeutic strategiesRyo Fukuda, Yukio Fujiwara, Toru Maruyama, et al.
Journal of Pharmaceutical Sciences|March 18, 2017
Clinical Implications Associated With the Posttranslational Modification-Induced Functional Impairment of Albumin in Oxidative Stress-Related DiseasesHiroshi Watanabe, Tadashi Imafuku, Masaki Otagiri, et al.
Journal of Functional Biomaterials|March 25, 2017
Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen CarriersKazuaki Taguchi, Keishi Yamasaki, Toru Maruyama, et al.
Chemical & Pharmaceutical Bulletin|July 3, 2020
Drug Delivery System for Refractory Cancer Therapy via an Endogenous Albumin Transport SystemYu Ishima, Toru Maruyama, Masaki Otagiri, et al.
Biomed Research International|February 4, 2014
Poly-s-nitrosated albumin as a safe and effective multifunctional antitumor agent: characterization, biochemistry and possible future therapeutic applicationsYu Ishima, Ulrich Kragh-Hansen, Toru Maruyama, et al.
Drug Metabolism and Pharmacokinetics|September 12, 2009
Albumin as a nitric oxide-traffic protein: characterization, biochemistry and possible future therapeutic applicationsYu Ishima, Ulrich Kragh-Hansen, Toru Maruyama, et al.
Journal of Pharmaceutical Sciences|April 18, 2017
The Use of Hemoglobin Vesicles for Delivering Medicinal Gas for the Treatment of Intractable DisordersKazuaki Taguchi, Keishi Yamasaki, Hiromi Sakai, et al.
Biochimica Et Biophysica Acta|May 14, 2013
Albumin-drug interaction and its clinical implicationKeishi Yamasaki, Victor Tuan Giam Chuang, Toru Maruyama, et al.
Journal of Arrhythmia|October 13, 2017
Intracoronary acetylcholine application as a possible probe inducing J waves in patients with early repolarization syndromeToru Maruyama, Kazumasa Fujita, Kei Irie, et al.
The Spine Journal : Official Journal of the North American Spine Society|July 30, 2011
Metastatic prostate cancer in ossification of the ligamentum flavum--a case reportTakao Motosuneya, Toru Maruyama, Hironobu Yamada, et al.
Pageof 39

Showing results (31-40 of 389) with videos related to

Sort By:
Pageof 39
Frontiers in Immunology|July 9, 2026
CD169-positive macrophages in lymph nodes and the tumor microenvironment: harnessing their biology for clinical diagnosis and anticancer therapeutic strategiesRyo Fukuda, Yukio Fujiwara, Toru Maruyama, et al.
Journal of Pharmaceutical Sciences|March 18, 2017
Clinical Implications Associated With the Posttranslational Modification-Induced Functional Impairment of Albumin in Oxidative Stress-Related DiseasesHiroshi Watanabe, Tadashi Imafuku, Masaki Otagiri, et al.
Journal of Functional Biomaterials|March 25, 2017
Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen CarriersKazuaki Taguchi, Keishi Yamasaki, Toru Maruyama, et al.
Chemical & Pharmaceutical Bulletin|July 3, 2020
Drug Delivery System for Refractory Cancer Therapy via an Endogenous Albumin Transport SystemYu Ishima, Toru Maruyama, Masaki Otagiri, et al.
Biomed Research International|February 4, 2014
Poly-s-nitrosated albumin as a safe and effective multifunctional antitumor agent: characterization, biochemistry and possible future therapeutic applicationsYu Ishima, Ulrich Kragh-Hansen, Toru Maruyama, et al.
Drug Metabolism and Pharmacokinetics|September 12, 2009
Albumin as a nitric oxide-traffic protein: characterization, biochemistry and possible future therapeutic applicationsYu Ishima, Ulrich Kragh-Hansen, Toru Maruyama, et al.
Journal of Pharmaceutical Sciences|April 18, 2017
The Use of Hemoglobin Vesicles for Delivering Medicinal Gas for the Treatment of Intractable DisordersKazuaki Taguchi, Keishi Yamasaki, Hiromi Sakai, et al.
Biochimica Et Biophysica Acta|May 14, 2013
Albumin-drug interaction and its clinical implicationKeishi Yamasaki, Victor Tuan Giam Chuang, Toru Maruyama, et al.
Journal of Arrhythmia|October 13, 2017
Intracoronary acetylcholine application as a possible probe inducing J waves in patients with early repolarization syndromeToru Maruyama, Kazumasa Fujita, Kei Irie, et al.
The Spine Journal : Official Journal of the North American Spine Society|July 30, 2011
Metastatic prostate cancer in ossification of the ligamentum flavum--a case reportTakao Motosuneya, Toru Maruyama, Hironobu Yamada, et al.
Pageof 39